According to Nkarta's latest financial reports the company has a price-to-book ratio of 1.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.19 | 50.86% |
2022-12-31 | 0.7856 | -61.02% |
2021-12-31 | 2.02 | -67.69% |
2020-12-31 | 6.24 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.92 | 53.11% | ๐บ๐ธ USA |